{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:46:02Z","timestamp":1772599562515,"version":"3.50.1"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is the most aggressive primary brain neoplasm in adults, characterized by high recurrence and poor post-recurrence survival. Validated quality indicators (QIs) have been used to assess the quality of care in many cancer populations, now providing clinicians, researchers, and healthcare policymakers with evidence-based metrics to enhance patient outcomes. In contrast, few glioblastoma-specific QIs have been described and their impact and meaningfulness are yet to be determined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A scoping review was conducted of described QIs for adult patients with GBM. The literature was screened for relevance, and eligible QIs were evaluated and grouped into 5 domains: pre-intervention, surgical, postsurgical, supportive care, and recurrence\/survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 80 articles were retrieved, with 12 of these studies meeting inclusion criteria. Twenty-six QIs were identified across the 5 care domains. Evidence linking these QIs directly to improved survival or quality of life is variable. Some QIs have solid evidence of impact (eg, accurate tissue diagnosis), while others are based on reasonably assumed benefits rather than robust evidence (eg, early palliative care referral). Frail or older patients and those with recurrent GBM are subsets with the least high-quality QIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Current QIs potentially provide valuable benchmarks to assess and optimize care in adults with glioblastoma, but many are yet to be supported by high-quality clinical evidence, with greater gaps in some patient populations. Further research is required to define and validate QIs that robustly assess quality of care, supporting urgent efforts to improve patient outcomes for this poor prognosis of cancer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/nop\/npaf037","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:39:44Z","timestamp":1743273584000},"page":"763-772","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating current quality indicators used in the care of adult patients with glioblastoma: A scoping review of the literature"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0387-4427","authenticated-orcid":false,"given":"Jainam","family":"Shah","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-4406","authenticated-orcid":false,"given":"Catherine","family":"Dunn","sequence":"additional","affiliation":[{"name":"Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Y","family":"Kim","sequence":"additional","affiliation":[{"name":"Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1423-4484","authenticated-orcid":false,"given":"Peter","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Western Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Gately","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Alfred Health , Melbourne, Victoria ,","place":["Australia"]},{"name":"Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"1","key":"2025100904420543800_CIT0001","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3389\/fonc.2020.00840","article-title":"Real-world evidence in glioblastoma: Stupp\u2019s regimen after a decade","volume":"10","author":"Lakomy","year":"2020","journal-title":"Front Oncol."},{"issue":"1","key":"2025100904420543800_CIT0002","doi-asserted-by":"crossref","first-page":"899710","DOI":"10.3389\/fimmu.2022.899710","article-title":"Recurrence-and malignant progression-associated biomarkers in low-grade gliomas and their roles in immunotherapy","volume":"13","author":"Teng","year":"2022","journal-title":"Front Immunol."},{"key":"2025100904420543800_CIT0003","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro Oncol."},{"issue":"6","key":"2025100904420543800_CIT0004","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"1","key":"2025100904420543800_CIT0005","first-page":"143","article-title":"Epidemiology and outcome of glioblastoma","volume":"1","author":"Tamimi","year":"2017","journal-title":"Exon Publications"},{"issue":"3","key":"2025100904420543800_CIT0006","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1215\/15228517-2008-093","article-title":"Quality of life in adults with brain tumors: current knowledge and future directions","volume":"11","author":"Liu","year":"2009","journal-title":"Neuro Oncol."},{"issue":"1","key":"2025100904420543800_CIT0007","first-page":"vdae028","article-title":"State of the neoadjuvant therapy for GBM-where do we stand","volume":"6","author":"Nabian","year":"2024","journal-title":"Neurooncol Adv."},{"issue":"1","key":"2025100904420543800_CIT0008","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.wneu.2017.04.041","article-title":"Extent of resection in glioma\u2013a review of the cutting edge","volume":"103","author":"D\u2019Amico","year":"2017","journal-title":"World Neurosurg"},{"issue":"1","key":"2025100904420543800_CIT0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00701-002-1030-6","article-title":"Debulking or biopsy of malignant glioma in elderly people\u2013a randomised study","volume":"145","author":"Vuorinen","year":"2003","journal-title":"Acta Neurochir."},{"issue":"10","key":"2025100904420543800_CIT0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"6","key":"2025100904420543800_CIT0011","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"2025100904420543800_CIT0012","article-title":"Gliomas","volume-title":"StatPearls [Internet]","author":"Mesfin","year":"2025"},{"issue":"4","key":"2025100904420543800_CIT0013","doi-asserted-by":"crossref","first-page":"352","DOI":"10.6004\/jnccn.2011.0036","article-title":"Central nervous system cancers","volume":"9","author":"Brem","year":"2011","journal-title":"J Natl Comprehen Cancer Netw"},{"issue":"3","key":"2025100904420543800_CIT0014","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/13814789709160336","article-title":"Indicators of quality in health care","volume":"3","author":"Lawrence","year":"1997","journal-title":"Eur J Gen Pract"},{"issue":"1","key":"2025100904420543800_CIT0015","first-page":"197","article-title":"Current standards of care in glioblastoma therapy","volume":"1","author":"Fernandes","year":"2017","journal-title":"Exon Publications"},{"issue":"7","key":"2025100904420543800_CIT0016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med."},{"issue":"2","key":"2025100904420543800_CIT0017","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-022-03971-3","article-title":"Quality indicators in neuro-oncology: Review of the literature and development of a new quality indicator set for glioma care through a two-round Delphi survey","volume":"157","author":"Vanhauwaert","year":"2022","journal-title":"J Neurooncol."},{"issue":"1","key":"2025100904420543800_CIT0018","first-page":"68","article-title":"What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry","volume":"9","author":"Matsuyama","year":"2022","journal-title":"Neurooncol. Pract.."},{"issue":"1","key":"2025100904420543800_CIT0019","first-page":"59","article-title":"Classical and disease-specific quality indicators in glioma surgery\u2014Development of a quality checklist to improve treatment quality in glioma patients","volume":"9","author":"Menke","year":"2022","journal-title":"Neurooncol. Pract.."},{"key":"2025100904420543800_CIT0020","author":"Scottish Cancer Taskforce","journal-title":"Brain and Central Nervous System Cancer Clinical Quality Performance Indicators 2024"},{"issue":"4","key":"2025100904420543800_CIT0021","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/neuonc\/nox245","article-title":"Quality improvement in neurology: Neuro-oncology quality measurement set","volume":"20","author":"Jordan","year":"2018","journal-title":"Neuro Oncol."},{"issue":"1","key":"2025100904420543800_CIT0022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2147\/CLEP.S99459","article-title":"The Danish neuro-oncology registry","volume":"8","author":"Hansen","year":"2016","journal-title":"Clin Epidemiol."},{"issue":"6","key":"2025100904420543800_CIT0023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JOP.2014.001556","article-title":"Improving the quality of care for patients diagnosed with glioma during the perioperative period","volume":"10","author":"Riblet","year":"2014","journal-title":"J Oncol Pract."},{"issue":"1","key":"2025100904420543800_CIT0024","doi-asserted-by":"crossref","first-page":"e2100405","DOI":"10.1200\/GO.21.00405","article-title":"Evaluating quality indicators of glioblastoma care: Audit results from an indian tertiary care cancer center","volume":"8","author":"Basu Achari","year":"2022","journal-title":"JCO Global Oncol."},{"key":"2025100904420543800_CIT0025","first-page":"e18880","article-title":"Assessing indicators of glioblastoma care quality in neuro-oncology centers: Baseline results of a pilot initiative","volume-title":"Neuro Oncol Pract","author":"Zada","year":"2018"},{"issue":"1","key":"2025100904420543800_CIT0026","doi-asserted-by":"crossref","first-page":"100438","DOI":"10.1016\/j.jcpo.2023.100438","article-title":"European Cancer Organisation essential requirements for quality cancer care: Adult glioma","volume":"38","author":"Bozzao","year":"2023","journal-title":"J Cancer Policy"},{"issue":"10","key":"2025100904420543800_CIT0027","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/brainsci8100186","article-title":"Optimising outcomes for glioblastoma through subspecialisation in a regional cancer centre","volume":"8","author":"Back","year":"2018","journal-title":"Brain Sci"},{"key":"2025100904420543800_CIT0028","volume-title":"Queensland Brain Cancer Quality Index: Practice Indicators of Safe, Quality Cancer Care, Public and Private Hospitals 2011-2020","author":"Queensland Government","year":"2023"},{"issue":"5","key":"2025100904420543800_CIT0029","doi-asserted-by":"crossref","first-page":"347","DOI":"10.47102\/annals-acadmedsg.V36N5p347","article-title":"Improvements in quality of care resulting from a formal multidisciplinary tumour clinic in the management of high-grade glioma","volume":"36","author":"Back","year":"2007","journal-title":"Ann Acad Med Singapore."},{"issue":"4","key":"2025100904420543800_CIT0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.2006.06.209","article-title":"Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: A randomized controlled trial","volume":"24","author":"Rummans","year":"2006","journal-title":"J Clin Oncol."},{"issue":"2","key":"2025100904420543800_CIT0031","first-page":"142","article-title":"Retrospective single-center study on elderly patients with glioblastoma between 2014 and 2018 evaluating the effect of age and performance status on survival","volume":"9","author":"Pirkkalainen","year":"2022","journal-title":"Neurooncol. Pract."},{"issue":"22","key":"2025100904420543800_CIT0032","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1002\/cncr.27570","article-title":"Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older","volume":"118","author":"Scott","year":"2012","journal-title":"Cancer."},{"issue":"3","key":"2025100904420543800_CIT0033","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2010.06.012","article-title":"Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma","volume":"81","author":"Li","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"3","key":"2025100904420543800_CIT0034","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1215\/S1152851703000620","article-title":"Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis","volume":"6","author":"Lamborn","year":"2004","journal-title":"Neuro Oncol."},{"issue":"1","key":"2025100904420543800_CIT0035","first-page":"100761","article-title":"Management of glioblastoma in elderly patients: A review of the literature","volume":"46","author":"Mazarakis","year":"2024","journal-title":"Clin Transl Radiat Oncol."},{"issue":"8","key":"2025100904420543800_CIT0036","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy\u2013temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med."},{"issue":"6","key":"2025100904420543800_CIT0037","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/nan.12031","article-title":"1p\/19q testing has no significance in the workup of glioblastomas","volume":"39","author":"Clark","year":"2013","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"3","key":"2025100904420543800_CIT0038","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1309\/AJCPFO8IIDNBIJ8Y","article-title":"How molecular testing can help (and hurt) in the workup of gliomas","volume":"139","author":"Clark","year":"2013","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"2025100904420543800_CIT0039","first-page":"249","article-title":"Prognosis in IDH-Mutant and IDH-wild type glioblastoma","volume":"43","author":"K\u0131l\u0131\u00e7","year":"2021","journal-title":"Cumhuriyet Med. J."},{"issue":"7","key":"2025100904420543800_CIT0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","article-title":"Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial","volume":"13","author":"Wick","year":"2012","journal-title":"Lancet Oncol."},{"issue":"1","key":"2025100904420543800_CIT0041","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jocn.2019.04.028","article-title":"Survival trends in glioblastoma and association with treating facility volume","volume":"68","author":"Aulakh","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"2025100904420543800_CIT0042","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3171\/2018.10.JNS182247","article-title":"Improved survival of glioblastoma patients treated at academic and high-volume facilities: A hospital-based study from the National Cancer Database","volume":"132","author":"Zhu","year":"2019","journal-title":"J Neurosurg."},{"issue":"2","key":"2025100904420543800_CIT0043","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001","journal-title":"J Neurosurg."},{"issue":"11","key":"2025100904420543800_CIT0044","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/jamaoncol.2016.3806","article-title":"Extent of resection and survival in glioblastoma multiforme","volume":"2","author":"Grasso","year":"2016","journal-title":"JAMA Oncol"},{"issue":"6","key":"2025100904420543800_CIT0045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1215\/15228517-2008-052","article-title":"Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients","volume":"10","author":"Pichlmeier","year":"2008","journal-title":"Neuro Oncol."},{"issue":"4","key":"2025100904420543800_CIT0046","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","article-title":"Association of maximal extent of resection of contrast-enhanced and non\u2013contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma","volume":"6","author":"Molinaro","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"2025100904420543800_CIT0047","first-page":"364","article-title":"Safe surgery for glioblastoma: Recent advances and modern challenges","volume":"9","author":"Gerritsen","year":"2022","journal-title":"Neurooncol Pract."},{"issue":"5","key":"2025100904420543800_CIT0048","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3171\/2022.1.JNS212566","article-title":"Between-hospital variation in time to glioblastoma surgery: A report from the Quality Registry Neuro Surgery in the Netherlands","volume":"137","author":"De Swart","year":"2022","journal-title":"J Neurosurg."},{"issue":"1","key":"2025100904420543800_CIT0049","first-page":"vdab053","article-title":"Timing of glioblastoma surgery and patient outcomes: A multicenter cohort study","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Neurooncol Adv."},{"issue":"3","key":"2025100904420543800_CIT0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol."},{"issue":"6","key":"2025100904420543800_CIT0051","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2014.9.FOCUS14479","article-title":"Time window for postoperative reactive enhancement after resection of brain tumors: Less than 72 hours","volume":"37","author":"Lescher","year":"2014","journal-title":"Neurosurg Focus."},{"issue":"3","key":"2025100904420543800_CIT0052","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/j.crad.2023.11.017","article-title":"Post-treatment imaging of gliomas: Challenging the existing dogmas","volume":"79","author":"Bhattacharya","year":"2023","journal-title":"Clin Radiol."},{"issue":"6","key":"2025100904420543800_CIT0053","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1215\/15228517-2009-005","article-title":"Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma","volume":"11","author":"Pirzkall","year":"2009","journal-title":"Neuro-Oncology."},{"issue":"1","key":"2025100904420543800_CIT0054","first-page":"1","article-title":"Imaging timing after surgery for glioblastoma: An evaluation of practice in Great Britain and Ireland (INTERVAL-GB)-a multi-centre, cohort study","volume":"6","author":"British Neurosurgical Trainee Research Collaborative (BNTRC)","year":"2024","journal-title":"J Neurooncol."},{"issue":"2","key":"2025100904420543800_CIT0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clon.2005.08.017","article-title":"Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment","volume":"18","author":"Burnet","year":"2006","journal-title":"Clin Oncol"},{"issue":"3","key":"2025100904420543800_CIT0056","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11060-010-0429-9","article-title":"Glioblastoma multiforme of the elderly: The prognostic effect of resection on survival","volume":"103","author":"Ewelt","year":"2011","journal-title":"J Neurooncol."},{"issue":"9","key":"2025100904420543800_CIT0057","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.21037\/tcr-20-1718","article-title":"Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl Cancer Res."},{"issue":"3","key":"2025100904420543800_CIT0058","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-007-9426-z","article-title":"Delay in radiotherapy shortens survival in patients with high grade glioma","volume":"85","author":"Irwin","year":"2007","journal-title":"J Neurooncol."},{"issue":"5","key":"2025100904420543800_CIT0059","first-page":"575","article-title":"The impact of brain cancer care coordinators on healthcare utilization and outcomes in patients with glioblastoma","volume":"11","author":"Hong","year":"2024","journal-title":"Neurooncol. Pract."},{"key":"2025100904420543800_CIT0060","doi-asserted-by":"publisher","article-title":"\u201cYou need someone steering the ship for you\u201d: Australian brain tumour care coordination needs, practices, and opportunities","author":"Cootes","DOI":"10.21203\/rs.3.rs-2298960\/v1"},{"issue":"1","key":"2025100904420543800_CIT0061","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12913-021-06476-3","article-title":"Care plus study: A multi-site implementation of early palliative care in routine practice to improve health outcomes and reduce hospital admissions for people with advanced cancer: A study protocol","volume":"21","author":"Philip","year":"2021","journal-title":"BMC Health Serv Res."},{"issue":"1","key":"2025100904420543800_CIT0062","doi-asserted-by":"crossref","first-page":"103219","DOI":"10.1016\/j.nicl.2022.103219","article-title":"Presurgical predictors of early cognitive outcome after brain tumor resection in glioma patients","volume":"36","author":"Zangrossi","year":"2022","journal-title":"NeuroImage: Clin."},{"issue":"4","key":"2025100904420543800_CIT0063","first-page":"328","article-title":"The Aftercare Survey: Assessment and intervention practices after brain tumor surgery in Europe","volume":"9","author":"Sierpowska","year":"2022","journal-title":"Neurooncol. Pract.."},{"issue":"suppl 6","key":"2025100904420543800_CIT0064","doi-asserted-by":"crossref","first-page":"vi143","DOI":"10.1093\/annonc\/mdv348.33","article-title":"Early rehabilitation after surgery for glioblastoma multiforme: Report from a monocentric experience","volume":"26","author":"Lanzetta","year":"2015","journal-title":"Ann Oncol."},{"issue":"1","key":"2025100904420543800_CIT0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11060-024-04785-1","article-title":"Age-independent benefits of postoperative rehabilitation during chemoradiotherapy on functional outcomes and survival in patients with glioblastoma","volume":"170","author":"Natsume","year":"2024","journal-title":"J Neurooncol."},{"issue":"9930","key":"2025100904420543800_CIT0066","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","article-title":"Early palliative care for patients with advanced cancer: A cluster-randomised controlled trial","volume":"383","author":"Zimmermann","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"2025100904420543800_CIT0067","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol."},{"issue":"12","key":"2025100904420543800_CIT0068","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2176\/nmc.ra.2017-0009","article-title":"Glioblastoma treatment in the elderly","volume":"57","author":"Okada","year":"2017","journal-title":"Neurol Med Chir (Tokyo)."},{"issue":"9","key":"2025100904420543800_CIT0069","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: The Nordic randomised, phase 3 trial","volume":"13","author":"Malmstr\u00f6m","year":"2012","journal-title":"Lancet Oncol."}],"container-title":["Neuro-Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nop\/advance-article-pdf\/doi\/10.1093\/nop\/npaf037\/62831191\/npaf037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/12\/5\/763\/62831191\/npaf037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/12\/5\/763\/62831191\/npaf037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:43:01Z","timestamp":1759999381000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nop\/article\/12\/5\/763\/8102802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,1]]},"published-print":{"date-parts":[[2025,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/nop\/npaf037","relation":{},"ISSN":["2054-2577","2054-2585"],"issn-type":[{"value":"2054-2577","type":"print"},{"value":"2054-2585","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,4,1]]}}}